How much funding has Nanochon raised?

Nanochon has raised $24.6M in total funding, most recently a Seed round.

Who are Nanochon's investors?

Nanochon's investors include cultivate(MD), Ecphora Capital, TEDCO, Cambridge Angels group, Empirical Ventures, Angel investors.

Where is Nanochon headquartered?

Nanochon is headquartered in Tokyo, United States.

What industry is Nanochon in?

Nanochon operates in Healthcare, Biotech, Medical Devices.

Nanochon

Repairing Your Active Life

Tokyo, United States · $24.6M raised

Healthcare

Biotech

Medical Devices

Headquarters: Tokyo
Employees: 1–10
Business Model: B2B
Website: nanochon.com

Total Funding: $24.6M
Last Round: $11.3M SeedMar 2026
Rounds: 6

About

Nanochon is a medical device company advancing orthopedic care with Chondrograft™, a 3D-printed, off-the-shelf implant designed to repair cartilage damage in the knee. Targeting 'pre-replacement' patients — those with focal cartilage defects who need more than temporary relief but aren't yet candidates for joint replacement — Chondrograft uses nanomaterial and 3D-printed collagen-mimicking structures to draw in blood and active cells from underlying bone, supporting the body's natural healing processes. The company completed a $4.1M oversubscribed Seed Prime II round in early 2026 to fund its first-in-human clinical trial.

Summary

Nanochon is a Healthcare company based in Tokyo, United States. It has raised $24.6M in total across 6 rounds, most recently a $11.3M Seed round in Mar 2026. Investors include cultivate(MD), Ecphora Capital and TEDCO.